BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 10719304)

  • 21. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.
    Song YC; Tang SJ; Lee TP; Hung WC; Lin SC; Tsai CY; Ng WV; Wu MF; Sun KH
    Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro suppression of anti-DNA antibody and immunoglobulin synthesis in systemic lupus erythematosus patients by human gamma interferon.
    Braude IA; Hochberg MC; Arnett FC; Waldmann TA
    J Rheumatol; 1988 Mar; 15(3):438-44. PubMed ID: 3132556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of interleukin-10 and of interleukin-12 on the in vitro production of anti-double-stranded DNA antibodies from patients with systemic lupus erythematosus.
    Tyrrell-Price J; Lydyard PM; Isenberg DA
    Clin Exp Immunol; 2001 Apr; 124(1):118-25. PubMed ID: 11359450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis.
    Linker-Israeli M; Deans RJ; Wallace DJ; Prehn J; Ozeri-Chen T; Klinenberg JR
    J Immunol; 1991 Jul; 147(1):117-23. PubMed ID: 2051017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles.
    Cambridge G; Leandro MJ; Teodorescu M; Manson J; Rahman A; Isenberg DA; Edwards JC
    Arthritis Rheum; 2006 Nov; 54(11):3612-22. PubMed ID: 17075806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naturally occurring V region connected antibodies inhibit anti-dsDNA antibody reactivity with dsDNA.
    Srdic-Rajic T; Jurisic V; Andrejevic S; Bonaci-Nikolic B; Bowker T; Concas D; Metlas R
    Immunobiology; 2012 Jan; 217(1):111-7. PubMed ID: 21840618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-phospholipid antibodies contribute to arteriosclerosis in patients with systemic lupus erythematosus through induction of tissue factor expression and cytokine production from peripheral blood mononuclear cells.
    Motoki Y; Nojima J; Yanagihara M; Tsuneoka H; Matsui T; Yamamoto M; Ichihara K
    Thromb Res; 2012 Oct; 130(4):667-73. PubMed ID: 22196362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of interleukin-12 and its signaling molecules in peripheral blood mononuclear cells in systemic lupus erythematosus patients.
    Li Z; Li Y; Huang L; Xu H; Yu X; Ye R
    Chin Med J (Engl); 2002 Jun; 115(6):846-50. PubMed ID: 12123550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
    Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
    Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus.
    Suzuki N; Sakane T; Engleman EG
    J Clin Invest; 1990 Jan; 85(1):238-47. PubMed ID: 1688569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
    Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of calcitonin gene-related peptide on apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Liu C; Chen X; Jin Y; Qu R; Jiang PF; Wen GM; Tang ZH
    Clin Exp Dermatol; 2007 Nov; 32(6):650-3. PubMed ID: 17725664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus.
    Kurosaka D; Yasuda J; Yoshida K; Yoneda A; Yasuda C; Kingetsu I; Toyokawa Y; Yokoyama T; Saito S; Yamada A
    J Rheumatol; 2006 Jun; 33(6):1102-7. PubMed ID: 16755657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals.
    Gutiérrez MA; Molina JF; Jara LJ; García C; Gutiérrez-Ureña S; Cuéllar ML; Gharavi A; Espinoza LR
    Int Arch Allergy Immunol; 1996 Mar; 109(3):229-35. PubMed ID: 8620091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
    Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.
    Lövgren T; Eloranta ML; Båve U; Alm GV; Rönnblom L
    Arthritis Rheum; 2004 Jun; 50(6):1861-72. PubMed ID: 15188363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.